Tahini Sold Nationwide Recalled Due to Potential Salmonella Contamination—Here's What to Know
The Food and Drug Administration (FDA) has announced a recall on tahini sesame paste because it may be contaminated with salmonella. The affected products were distributed throughout the United States.
New Jersey-based Turkana Food Inc. is recalling its Aleppo Tahini Sesame Paste after sampling preformed by the Ohio Department of Agriculture revealed it may be contaminated with salmonella. Production and distribution of the products have stoped until the root of the problem is discovered, according to the FDA.
Related: Chocolate Recall Considered Class I Due to 'Deadly' Allergen Risk, FDA Warns
The recalled products were sold in 16-ounce plastic jars and have a LOT number of 120824, UPC 854643003054, and expiration date of August 2026. The products were distributed in the following states: Florida, Kentucky, Virginia, New York, New Jersey, Tennessee, Massachusetts, Texas, Illinois, Indiana, Michigan, Rhode Island, Pennsylvania, Maryland, Ohio, Alabama, Montana, and California.
Per the FDA, salmonella is an organism that can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Symptoms include nausea, vomiting, diarrhea or bloody diarrhea, abdominal cramping, and fever.
While no illnesses related to this recall have been reported, the FDA is urging consumers to return the product to the place of purchase for a full refund or throw it away immediately. Those with questions can contact Turkana Foods Inc. by calling 908-810-8800 or emailing info@turkanafood.com Monday through Friday, 8 a.m. to 6 p.m. EST.
Read the original article on Martha Stewart
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Axios
2 hours ago
- Axios
Exclusive: Zorro clinches $20M Series A for ICHRA health plans
Health benefits provider Zorro raised $20 million in Series A funding led by Entrée Capital, CEO Guy Ezekiel tells Axios exclusively. Why it matters: As employers wrestle with rising health plan costs, individual coverage health reimbursement arrangements (ICHRAs) are gaining steam. Driving the news: Launched in 2020, ICHRAs were enabled by a Trump-era rule letting employers reimburse employees tax-free for individual health insurance instead of offering group plans. After a slow start, rule clarifications and compliance tools made them more accessible to midsized employers. Follow the money: Existing backers Pitango and 10D joined the round, which will be used to scale operations and improve support for employers. The Series A brings Zorro to $31.5 million total raised. The company is not yet profitable. How it works: New York City-based Zorro replaces traditional group plans with defined-contribution models. Employers set a budget; employees use Zorro's AI engine to select personalized plans, and brokers get real-time tools to compare group plans versus ICHRA-based options. When it onboards an employer, Zorro asks them to send their benefits roster from the previous year, asks about quality and budget priorities for the upcoming year, and helps predict what benefits employees might want next. Zorro has "several thousand" lives on the platform, per Ezekiel. Between the lines: Zorro's pitch hinges not just on cost control but on its ability to shift complex decision-making from HR to software — claiming that 75% of users enroll without human help. What they're saying: "We're giving the employer a line of sight to how his upcoming year is going to look," says Ezekiel. Reality check: While ICHRAs are gaining traction, they remain a small fraction of the employer market. Zorro's long-term success depends on widespread broker adoption and employee trust in AI-led benefit decisions. State of play: A February Bailey's report predicted the debut of several new ICHRA startups in 2025. Several others have secured recent funding. In April, Thatch raised $40 million in Series B funding led by Index Ventures and Venteur Health Insurance raised a $20 million Series A led by Informed Ventures and American Family Ventures. Remodel Health last December collected more than $100 million in a round led by Oak HC/FT and Hercules Capital.
Miami Herald
6 hours ago
- Miami Herald
The possibly fatal reason gummies sold at Aldi, BJ's and on Amazon got recalled
Conflicting test results indicating a potential allergy danger caused the manufacturer of vitamin B12 gummies to recall them nationwide. Vita Warehouse made Welby Vitamin B12 Energy Support gummies 1000 mcg for Aldi, Berkely Jensen Vitamin B12 1000 mcg gummies for BJ's Warehouse Club, and sells VitaGlobe Vitamin B12 Extra Strength gummies through its website. The gummies should be peanut free, as indicated on the label's ingredient listing. But, Vita Warehouse said in its FDA-posted recall notice, Aldi's routine testing for allergen listing accuracy 'indicated a potential presence of a peanut allergen. Although internal testing conducted by Vita Warehouse Corp. has verified the absence of peanuts in the product, the recall is being initiated out of an abundance of caution to ensure consumer safety and trust.' Because, if Aldi's testing is correct and someone with a peanut allergy gulps the gummies, Vita Warehouse's notice says, there's a 'risk of serious or life-threatening allergic reaction.' Each of the bottles has lot No. 248046601 with an October 2026 expiration date of October 2026. If you have them and they might be taken by someone who has a peanut allergy, return them to your seller for a refund. If you have questions, call Vita Warehouse at 855-214-0100, Monday through Friday, 7:30 a.m. to 4 p.m., Eastern time.
Yahoo
7 hours ago
- Yahoo
Best Rice for Diabetics That Won't Spike Your Blood Sugar
If you've been watching your blood sugar or have been diagnosed with diabetes, your doctor has undoubtedly told you to rein in the amount of carbohydrates you eat. But choosing the right kind of carbs is also key, since refined carbs like white rice have a more pronounced effect on blood sugar than complex ones. So, what is the best rice for diabetics? We reveal the top varieties of rice that won't spike your blood sugar. White rice is on the American Diabetes Association's 'eat less' list for good reason. 'Generally speaking, if you're eating white rice as a staple in your diet, it can spike insulin levels and blood sugar levels when it's part of your daily consumption,' notes Michelle Routhenstein, MS, RD, CDCES, CDN, a preventive cardiology dietitian and certified diabetes educator. But that doesn't mean people with diabetes need to give up rice entirely. A scale known as the glycemic index (GI) ranks carb-containing foods on a scale of 0 to 100, based on how much they increase blood sugar after eating. And according to Reema Patel, MD, diabetes and metabolism endocrinologist at Old Bridge Medical Center in New Jersey, white rice has a GI of 70 to 90. The processing and refining that white rice undergoes strips away its bran and germ, she explains. 'That removes its fiber and other nutrients, which is why white rice becomes high-GI.' That's a concern, since a study in the International Journal of Advances in Medicine showed that eating high-GI white rice made it tougher for people with type 2 diabetes to control their fasting blood glucose and HbA1C levels compared to other rice types. It goes without saying that your best bet is scaling back on refined grains like white rice whenever possible. So that begs the question: What is the best rice for diabetics? Whole-grain rice varieties are better GI choices, since they retain their high-fiber germ and bran. And as Dr. Patel notes, they're higher in antioxidants, compounds that enhance cells' sensitivity to insulin. Here, the types of rice she recommends for diabetics or those watching their blood sugar, along with their GI values: Red rice: GI 55 Brown rice: GI 50 Wild rice: GI 45 Black rice (aka forbidden rice): GI 35 If white rice is still your favorite, three simple steps can make it more diabetic-friendly and reduce the risk of a glucose spike: Just cook, cool and reheat before eating. 'When you cook rice and allow it to cool, it undergoes a molecular process called retrogradation where some of the starch is converted into resistant starch that is less digestible,' explains Tiffany Bruno, MS, RDN, director of education at Switch4Good. 'This means it will not raise blood glucose levels as much, even after it is reheated.' Indeed, a study in the Asia Pacific Journal of Clinical Nutrition found that blood sugar surges were 31 percent lower after eating cooked and cooled white rice than after eating freshly-cooked white rice. Even the best types of rice for diabetics are high in carbohydrates, so Dr. Patel advises limiting your intake to 1/3 to ½ cup per day. Also smart: Eating your rice in conjunction with foods that assist in blood sugar and insulin balance. 'My biggest tip is to add fiber to the meal to help slow digestion and reduce the blood glucose spike that naturally occurs after consuming carbohydrates,' says Bruno. 'Vegetables and beans are the best way, so think of something like a chickpea curry or refried beans with roasted veggies.' Dr. Patel also recommends adding protein sources such as salmon, chicken, tofu and edamame to rice. Protein also slows carbohydrate digestion and glucose absorption. And in a British Journal of Nutrition study, incorporating protein into meals blunted the blood-sugar climbs caused by white rice. Finally, bear in mind that the impact that rice has on blood sugar levels can vary from person to person. 'Every person has a different blood sugar response to rice, and every patient has their own blood sugar and HBa1C goals,' notes Dr. Patel. That's why she stresses that it's important to work with your physician to monitor your blood glucose on a regular basis. More ways to manage your blood sugar: The Best Low-Sugar Fruits to Stabilize Your Blood Sugar Naturally Love Cheese? These Options Are Blood Sugar-Friendly and Safe for Diabetics The 5 Best Sugar Substitutes Diabetics Love—They Taste Great and Keep Blood Sugar Steady! This content is not a substitute for professional medical advice or diagnosis. Always consult your physician before pursuing any treatment plan.
